Fred Mermelstein

Board Member at Courage Therapeutics

Fred is an experienced bio-tech entrepreneur and investor involved in the development of multiple products from the lab bench through FDA approval. He is co- Founder and chairman of the Board of SanaRx Biotherapeutics. He was co-founder & Chairman of the Board Pear Tree Pharmaceuticals, Inc. which Merged with Dare Biosciences (Nasdaq: DARE), founder of Javelin Pharmaceuticals, Inc. (NYSE: JAV; Merged with Hospira/Pfizer), founder & CSO of PolaRx Biopharmaceuticals, Inc., Merged with (NYSE: Teva), NXPG Development Corp acquired by SBI Pharma and former director of Cardiome Pharma (Nasdaq: CRME). Fred brings experience in biotech investment working in venture capital as a director at Paramount Biocapital, Inc.

Timeline

  • Board Member

    Current role